Increased colonic transit in rats produced by a combination of a cholinesterase inhibitor with a 5-HT4 receptor agonist

Neurogastroenterology and Motility

Volumn 21, Issue 11, 2009, Pages

  Campbell Dittmeyer, K ^c   Hicks, G A ^b,d   Earnest, D L ^d   Greenwood Van Meerveld, B ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MALLINCKRODT PHARMACEUTICALS   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

5 HT4; Colonic transit; Neostigmine; Synergy; Tegaserod

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; NEOSTIGMINE; PROKINETIC AGENT; TEGASEROD;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC NERVE; CHOLINERGIC STIMULATION; CHOLINERGIC SYNAPSE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEFECATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FECES; INTESTINE MUSCLE; INTESTINE TRANSIT TIME; MALE; MUSCLE INNERVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CHOLINESTERASE INHIBITORS; COLON; DEFECATION; GASTROINTESTINAL TRANSIT; INDOLES; MALE; NEOSTIGMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN 5-HT4 RECEPTOR AGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 70349668659     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01238.x     Document Type: Article

References (21)

1. Rizzi CA, Coccini T, Onori L, Manzo L, Tonini M. Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum. J Pharmacol Exp Ther 1992 261 : 412 419.
2. Ramirez B, Richter JE. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993 7 : 5 20.
3. De Giorgio R, Barbara G, Stanghellini V et al. Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther 2001 15 : 1717 1727.
4. Camilleri M. Review article: tegaserod. Aliment Pharmacol Ther 2001 15 : 277 289.
5. Beglinger C. Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome. Int J Clin Pract 2002 56 : 47 51.
6. Degen L, Matzinger D, Merz M et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001 15 : 1745 1751.
7. Cellek S, John AK, Thangiah R et al. 5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle. Neurogastroenterol Motil 2006 18 : 853 861.
8. Nguyen A, Camilleri M, Kost LJ et al. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther 1997 280 : 1270 1276.
9. Beattie DT, Smith JA, Marquess D et al. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol 2004 143 : 549 560.
10. Zittel TT, Huge A, Kreis ME, Becker HD, Jehle EC. HTF 919, a new 5-HT4 receptor agonist, increases postoperative gastric and small intestinal motility in rats. Gastroenterology 1999 116 : A1108.
11. Huge A, Zittel TT, Kreis ME, Becker HD, Jehle EC. Effects of tegaserod (HTF 919) on gastrointestinal motility and transit in awake rats. Gastroenterology 2000 118 (Suppl. 2 A403.
12. Weber E, Braun B, Forgiarini P, Pfannkuche HJ. Tegaserod normalizes opioid-induced bowel dysfunction in dogs. Gastroenterology 2003 124 (Suppl. 1 A571.
13. Taniyama K, Makimoto N, Furuichi A et al. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol 2000 35 : 575 582.
14. Leclere PG, Prins NH, Schuurkes JA, Lefebvre RA. 5-HT4 receptors located on cholinergic nerves in human colon circular muscle. Neurogastroenterol Motil 2005 17 : 366 375.
15. Prins NH, Akkermans LM, Lefebvre RA, Schuurkes JA. 5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle. Br J Pharmacol 2000 131 : 927 932.
16. Cellek S, Thangiah R, Jarvie EM, Vivekanandan S, Lalude O, Sanger GJ. Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach. Neurogastroenterol Motil 2008 20 : 539 545.
17. Kilbinger H, Wolf D. Effects of 5-HT4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1992 345 : 270 275.
18. Ren J, Zhou X, Galligan JJ. 5-HT4 receptor activation facilitates recovery from synaptic rundown and increases transmitter release from single varicosities of myenteric neurons. Am J Physiol Gastrointest Liver Physiol 2008 294 : G1376 83.
19. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999 341 : 137 141.
20. Greenwood-Van Meerveld B, Venkova K, Hicks G, Dennis E, Crowell MD. Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterol Motil 2006 18 : 76 86.
21. Borman RA, Tilford NS, Harmer DW et al. 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol 2002 135 : 1144 1151.